Psychosocial burden of abnormal Pap smears among HIV-infected women at Chon Buri Hospital, Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 1, 2010, Pages 224-234

  Jayathunge, Mangala P H ^a   Bowanwatanuwong, Chureeratana ^b   Maek A nantawat, Wirach ^a   Phonrat, Benjaluck ^a   Pitisuttithum, Punnee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Department of Internal Medicine   (Thailand)

Author keywords

Cervical cancer; HIV infected; HPV; Human papillomavirus; Pap smears; Psychosocial burden; Thailand

Indexed keywords

EID: 76949097490     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Arends MJ, Buckley CH, Wells M. Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol 1998;51:96-103.
2. Bennetts A, Irwig L, Oldenburg B, et al. PEAPS-Q: a questionnaire to measure the psychosocial effects of having an abnormal pap smear. Psychosocial Effects of Abnormal Pap Smears Questionnaire. J Clin Epidemiol 1995;48:1235-43.
3. Centers for Disease Control and Prevention, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mort Wkly Rep 1993;41:1-19.
4. Deacon JM, Evans CD, Yule R, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. BrJ Cancer 2000;83:1565-72.
5. Delmas MC, Larsen C, Van Benthem B. Cervical squamous intraepithelial lesions in HIV infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AJDS 2000;14:1775-84.
6. Ellerbrock TV, Chiasson MA, Bush TJ. Incidence of cervical squamous intraepithelial neoplasia in HIV infected women. JAMA 2000;283:1031-7.
7. Hawes SE, Critchlow CW, Faye Niang MA. Increased risk of high-grade cervical squamous intraepithelial lesions and cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003;188:555-63.
8. Herzog TJ, Wright JD. The impact of cervical cancer on quality of life-The components and means for management. Gynecol Oncol 2007;107:572-7.
9. Hluangdansakul W, Phinchantra P, Bowonwatanuwong C. Prevalence of SIL and SCCA in human immunodeficiency virusseropositive women at anonymous clinic in Chonburi Hospital. J Med Assoc Thai 2006;89:289-93.
10. Jones MH, Singer A, Jenkins D. The mildly abnormal cervical smear: patient anxiety and choice of management. J R Soc Med 1996;89:257-60.
11. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-51.
12. Kritpetcharat O, Suwanrungruang K, Sriamporn S, et al. Coverage of cervical cancer screening in Khon Kaen, northeast Thailand. Asian Pac J Cancer Prev 2003;4:103-5.
13. McDowell I. Measuring health: a guide to rating scales and questionnaires. Oxford, USA: Oxford University Press, 2006:305-8.
14. Maiman M, Frutchter RG, Clark M. Cervical cancer as an AIDS-defining illness. Obstet Gynaecol 1997;89:76-80.
15. Massad LS, Seaberg EC, Wright RL, et al. Squamous cervical lesions in women with human immunodeficiency virus long-term follow-up. Obstet Gynecol 2008;111:1388-93.
16. MaCaffery K, Waller J, Forrest S, et al. Testing positive for human papillomavirus in routine cervical screening:examination of psychosocial impact. BJOG 2004;111:1437-43.
17. Molassiotis A, Maneesakorn S. Quality of Life, coping and psychological status of Thai people living with AIDS. Psychol Health Med 2004;9:350-61.
18. Palefsky JM, Minkoff H, Kalish LA. Cervicovaginal human papillomavirus infection in human immunodeficiency virus (HIV) -l positive and high risk HIV-negative women. JNatl Cancer Inst 1999;91:226-36.
19. Schuman SE, Ohmit, Klein RS. HIV Epidemiology Research Study (HERS). Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV) seropositive and at risk HIV-seronegative women. J Infect Dis 2003;188:128-36.
20. The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
21. Womack SD, Chirenje ZM, Gaffikin L. HPV based cervical cancer screening in a population at high risk for HIV infection, lnt J Cancer 2000;85:206-10.
22. Wright TC, Ellerbrock TV, Chiasson MA. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and validity of Papanicolaou smears. Obstet Gynaecol 1994;84:591-7.